Evidence map›Paper›PMID 41713864›Full record

ArticleAmerican journal of perinatology2026

A Pathophysiological Approach for Early Detection and Prevention of AKI in the NICU.

Vignesh Gunasekaran, Soowan Woo, Parvathy Krishnan, Andrew M South, Jeffrey Shenberger, David Askenazi, Parvesh M Garg

Abstract read
In one paragraph

Article in American journal of perinatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vignesh Gunasekaran *Department of Pediatrics/Neonatology, West Virginia University School of Medicine, Martinsburg, West Virginia, United States.ORCID 0000-0003-1263-1822
Soowan Woo *Department of Pediatrics, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.ORCID 0009-0004-4038-7673
Parvathy KrishnanDivision of Newborn Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States.
Andrew M SouthDepartment of Pediatrics/Section of Nephrology, Wake Forest University School of Medicine, Winston Salem, North Carolina, United States.
Jeffrey ShenbergerDepartment of Pediatrics/Neonatology, Connecticut Children's, Hartford, Connecticut, United States.
David AskenaziDepartment of Pediatrics/Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, United States.
Parvesh M GargDepartment of Pediatrics/Neonatology, Atrium Health Wake Forest Baptist, Wake Forest School of Medicine, Winston Salem, North Carolina, United States.

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI COMPRETTA, CAROLINE E. · 2016 to 2025
$38.2M
NIGMS NIH HHS U54 GM115428NIGMS of the NIH U54GM115428NIH HHS NHLBI R01HL146818NIH HHS NIH NHLBI K23HL148394NIH HHS NIH NHLBI R01HL164434
6 · The paper itself

Abstract

This study aimed to summarize contemporary evidence on the definition, epidemiology, risk factors, and prevention of acute kidney injury (AKI) in critically ill and preterm infants in the neonatal intensive care unit (NICU), and to highlight prevention-focused strategies to improve outcomes. Narrative review of current literature evaluating AKI burden, diagnostic criteria, modifiable and nonmodifiable risk factors, and preventive interventions in neonatal intensive care settings. AKI is common in critically ill and preterm infants and is associated with increased mortality, prolonged hospitalization, neurodevelopmental impairment, and progression to chronic kidney disease. Modified Kidney Disease: Improving Global Outcomes criteria have improved diagnostic consistency and revealed particularly high AKI prevalence in extremely low birth weight infants. Key modifiable risk factors include hemodynamic instability, patent ductus arteriosus, nephrotoxic drug exposure, fluid overload, and sepsis, while preventive strategies span optimized antenatal management, therapeutic hypothermia for hypoxic ischemic encephalopathy, careful postnatal hemodynamic and fluid management, nephrotoxic drug stewardship, early infection control, individualized ductus arteriosus therapy, and potential use of caffeine, alongside emerging urinary biomarkers for earlier detection. Given limited therapeutic options once AKI occurs, prevention through structured surveillance, timely identification of high-risk states, and rigorous implementation of kidney protective practices is essential. Integrating quality improvement, protocolized care pathways, and educational outreach within NICUs offers the greatest promise for improving short and long-term outcomes in infants with AKI. · Structured post-AKI monitoring and quality improvement protocols reduce AKI incidence.. · Nephrotoxic medication protocols reduce AKI through proactive monitoring and dose optimization.. · Neonatal AKI is common and serious; prevention via fluids, hemodynamics, and med stewardship is key..

Identifiers

PMID41713864
PMCPMC12949978

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.